Loading...
Images of Solomon Bj
(0 from 0 )1
0
0
News
Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data - ILCN.org...
www.ilcn.org
Lancet Oncol ;18(12): Solomon BJ, Besse B, Bauer TM, et al. Lorlatinib in patients with ...
Crizotinib superior to chemotherapy for intracranial control in ALK...
www.healio.com
Crizotinib superior to chemotherapy for intracranial control in ALK-positive NSCLC. Solomon BJ, et al. J Clin Oncol
Network Profiles
LinkedIn: solomon bj | LinkedIn
View solomon bj's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like solomon bj discover inside ...
pinterest.com: BJ Solomon
1 Pin • 1 Follower
Interests
Re: Cancer drugs, survival, and ethics | The BMJ
www.bmj.com
(7) Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Education
classmates: Bj Solomon
Bastrop High School, Bastrop, TX,
classmates: Bj Solomon
Cranford High School, Cranford, NJ,
Books & Literature
Cumulated Index Medicus - Google Books
books.google.de
... Direct and Solomon BJ see Pedersen WL Indirect effects of nicotine on rabbit pancreatic Solomon C see Feldman G secretion . Gastroenterology 67 :
Impact of Genetic Targets on Cancer Therapy - Google Books
books.google.de
The volume provides a forum for original peer-reviewed short communications, full-length research and review articles on new research findings and...
Malignant Gliomas - Google Books
books.google.de
Lancet Oncol ;12(8):735–742. Shaw AT, Yeap BY, Solomon BJ, et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung ...
Related Documents
Page Read Onlineoaepublish.com › special_issue › cdr › files › basic-html
oaepublish.com
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, Moro-Sibilot D, Camidge ...
Page Read Onlinevpjournal.net › special_issue › jcmt › files › basic-html
vpjournal.net
J Clin Oncol 2011;29:e Leone JP, Leone BA. Breast cancer brain metastases: the last frontier Costa DB, Shaw AT, Ou SH, Solomon BJ, Riely GJ, ...
Scientific Publications
Ceritinib in ALK-rearranged non-small-cell lung cancer. - PubMed -...
pubmed.ncbi.nlm.nih.gov
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to...
The efficacy and safety of crizotinib in the treatment of anaplastic...
bmccancer.biomedcentral.com
Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, ...
Cancer-Related Publications | Cell Signaling Technology
www.cellsignal.com
Katayama R, Shaw AT, Khan TM, Mino-Kenudson M, Solomon BJ, Halmos B, Jessop NA, Wain JC, Yeo AT, Benes C, Drew L, Saeh JC, Crosby K, Sequist LV, ...
Effect of crizotinib on overall survival in patients with advanced...
pubmed.ncbi.nlm.nih.gov
Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA, Shapiro GI, Costa DB, Ou SH, Butaney M, Salgia R, Maki RG, ...
Publications
Deciding priorities in Pharma | SpringerLink
link.springer.com
Bang Y, Kwak EL, Shaw AT, Camidge DR, Iafrate AJ, Maki RG, Solomon BJ, Ou SI, Salgia R, Clark JW:
Citation:Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K ...wiki.cancer.org.au › australia › Citation:Solomon_BJ,_Mo...
wiki.cancer.org.au
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med
Use of targeted therapy for refractory ALK-positive anaplastic large...
link.springer.com
... Solomon BJ, Riely GJ et al (2011) Effect of Crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene ...
Citation:Laurie SA, Solomon BJ, Seymour L, Ellis PM, Goss GD,...
wiki.cancer.org.au
Laurie SA, Solomon BJ, Seymour L, Ellis PM, Goss GD, Shepherd FA, et al. Randomised, double-blind trial of carboplatin and paclitaxel with daily oral ce...
Reports & Statements
The cost-effectiveness of screening lung cancer patients for targeted...
www.nature.com
Clinical Study
A multicentre phase II trial of cabazitaxel in patients with advanced...
www.nature.com
Clinical Study
Miscellaneous
Leah Solomon & BJ Solomon - Baby Registry - Amherst - OH |...
www.myregistry.com
Leah Solomon and BJ Solomon of Amherst, OH have a baby registry at MyRegistry.com. View all of the items on one universal gift list.
Leah Solomon & Bj Solomon's Baby Registry on The Bump
registry.thebump.com
Leah and Bj from Amherst, OH have registered for their baby expected on August 18, View all of the items from their registries in one beautiful list.
A Study Of Oral PF , A C-Met/Hepatocyte Growth Factor...
clinicaltrials.gov
Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, Doebele RC, Le LP, Zheng ...
ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in...
journals.plos.org
Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA, et al. Effect of crizotinib on overall survival in patients with advanced ...
Alectinib as a treatment option following recovery from...
www.spandidos-publications.com
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, et al: Crizotinib versus chemotherapy in ...
FDA Grants Priority Review to Lorlatinib for ALK+ NSCLCwww.onclive.com › web-exclusives › fda-grants-priority-...
www.onclive.com
Solomon BJ, Shaw A, Ignatius Ou S-H, et al. Phase 2 Study of lorlatinib in patients with advanced ALK+/ROS1+ non-small-cell lung cancer.
Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma...
www.karger.com
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O'Byrne KJ, ...
Clinical Spotlight in ALK-Positive NSCLC From the Lung Cancer...
www.primeoncology.org
... advanced NSCLC patients. Presented by Fiona Blackhall. Publication Solomon BJ, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Frontiers | Biomarkers That Currently Affect Clinical Practice in...
www.frontiersin.org
Lung cancer remains the most lethal malignancy in the world. Despite improvements in surgical treatment, systemic therapy and radiotherapy, the 5-year survival...
Are We Making Progress in Lung Cancer Using Progression-Free Survival...
jamanetwork.com
Opinion from JAMA Oncology — Are We Making Progress in Lung Cancer Using Progression-Free Survival as a Surrogate End Point?
First-Line Crizotinib Improves Progression-Free Survival vs...
ascopost.com
Solomon BJ, Mok T, Kim DW, et al: First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371: ,
LCAF - Clinical: Lung Cancer, ALK (2p23) Rearrangement, FISH, Tissue
www.mayocliniclabs.com
Shaw AT, Yeap BY, Solomon BJ, et al: Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene ...
Papers & Posters | Cell Signaling Technology
www.cellsignal.com
Listing of IHC-related scientific posters and papers involving scientists from Cell Signaling Technology.
Reference Overview for COSMICcancer.sanger.ac.uk › cosmic › study › overview
cancer.sanger.ac.uk
Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Thomas M, Schuler ...
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung...
m.amedeo.com
Link provided by Amedeo Smart, the weekly medical literature survey for smartphones.
Renal complication of crizotinib: Crizotinib-associated ...www.asean-journal-radiology.org › ajr › article › view
www.asean-journal-radiology.org
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Revue de Presse - janvier 2013
www.pneumocancero.com
(9) Shaw AT, Varghese AM, Solomon BJ, Costa DB, Novello S, Mino-Kenudson M, et al. Pemetrexed-based chemotherapy in patients with advanced, ...
Sequential therapy according to distinct disease progression ...article.cjcrcn.org › article › app › reference
article.cjcrcn.org
Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 2014;371: [11]. Zhou J, Zheng J, ...
Related search requests for Solomon Bj
|
People Forename "Solomon" (4060) Name |
sorted by relevance / date